Dr. Steve Kheloussi (Highmark, Inc.) and Dana McCormick (BlueCross BlueShield Texas) delve into the complexities health plans face in managing treatments for atopic dermatitis. They explore innovative treatment options that have recently become available, the impact of these treatments on patient quality of life, and strategies health plans can implement to enhance patient outcomes. The conversation highlights the challenges in designing benefits to ensure timely access to evidence-based treatments, the lag in clinical guidelines following rapid advancements in therapy options, and the administrative hurdles that can impede patient care. The faculty also discuss the importance of payer-provider collaboration in addressing these issues and the potential for technology to streamline access and reduce administrative burdens. This discussion is essential for health plan professionals looking to navigate the intricacies of providing coverage for atopic dermatitis treatments effectively.
This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/atopicdermstrategies/.
POWERED BY BLUBRRY
